These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 24487394)

  • 21. Idiopathic pneumonia syndrome in mice after allogeneic bone marrow transplantation.
    Shankar G; Bryson JS; Jennings CD; Morris PE; Cohen DA
    Am J Respir Cell Mol Biol; 1998 Feb; 18(2):235-42. PubMed ID: 9476911
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone marrow mesenchymal stem cells suppress lymphocyte proliferation in vitro but fail to prevent graft-versus-host disease in mice.
    Sudres M; Norol F; Trenado A; Grégoire S; Charlotte F; Levacher B; Lataillade JJ; Bourin P; Holy X; Vernant JP; Klatzmann D; Cohen JL
    J Immunol; 2006 Jun; 176(12):7761-7. PubMed ID: 16751424
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Xenoreactivity of human clonal mesenchymal stem cells in a major histocompatibility complex-matched allogeneic graft-versus-host disease mouse model.
    Jeon MS; Lim HJ; Yi TG; Im MW; Yoo HS; Choi JH; Choi EY; Song SU
    Cell Immunol; 2010; 261(1):57-63. PubMed ID: 20004369
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bone Marrow Mesenchymal Stromal Cells from Patients with Acute and Chronic Graft-versus-Host Disease Deploy Normal Phenotype, Differentiation Plasticity, and Immune-Suppressive Activity.
    Copland IB; Qayed M; Garcia MA; Galipeau J; Waller EK
    Biol Blood Marrow Transplant; 2015 May; 21(5):934-40. PubMed ID: 25659882
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distinct immunomodulatory and migratory mechanisms underpin the therapeutic potential of human mesenchymal stem cells in autoimmune demyelination.
    Payne NL; Sun G; McDonald C; Layton D; Moussa L; Emerson-Webber A; Veron N; Siatskas C; Herszfeld D; Price J; Bernard CC
    Cell Transplant; 2013; 22(8):1409-25. PubMed ID: 23057962
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Effect of Ly49A transfected mouse spleen cells on graft versus host disease and graft versus leukemia after haploidentical allogeneic bone marrow transplantation in mice].
    Li Y; Guo K; Chen Y; Song Z; Li J; Deng L
    Zhonghua Xue Ye Xue Za Zhi; 2002 Aug; 23(8):411-4. PubMed ID: 12411044
    [TBL] [Abstract][Full Text] [Related]  

  • 27. IL-2 inhibits early increases in serum gamma interferon levels associated with graft-versus-host-disease.
    Szebeni J; Wang MG; Pearson DA; Szot GL; Sykes M
    Transplantation; 1994 Dec; 58(12):1385-93. PubMed ID: 7809932
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sca-1+Lin-CD117- mesenchymal stem/stromal cells induce the generation of novel IRF8-controlled regulatory dendritic cells through Notch-RBP-J signaling.
    Liu X; Ren S; Ge C; Cheng K; Zenke M; Keating A; Zhao RC
    J Immunol; 2015 May; 194(9):4298-308. PubMed ID: 25825436
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Injection of Sca-1+/CD45+/CD31+ mouse bone mesenchymal stromal-like cells improves cardiac function in a mouse myocardial infarct model.
    He J; Teng X; Yu Y; Huang H; Ye W; Ding Y; Shen Z
    Differentiation; 2013; 86(1-2):57-64. PubMed ID: 23974360
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recipient type-specific engineered regulatory T cells prevent graft-vs-host disease after allogeneic bone marrow transplantation in mice.
    Chen C; Cao J; Zeng L; Li Y; Wang D; Xu K
    Transplant Proc; 2011 Jun; 43(5):2041-8. PubMed ID: 21693322
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Expanded donor natural killer cell and IL-2, IL-15 treatment efficacy in allogeneic hematopoietic stem cell transplantation.
    Chen G; Wu D; Wang Y; Cen J; Feng Y; Sun A; Tang X; Chang H; Zhu Z
    Eur J Haematol; 2008 Sep; 81(3):226-35. PubMed ID: 18573173
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypoxic mesenchymal stem cells engraft and ameliorate limb ischaemia in allogeneic recipients.
    Huang WH; Chen HL; Huang PH; Yew TL; Lin MW; Lin SJ; Hung SC
    Cardiovasc Res; 2014 Feb; 101(2):266-76. PubMed ID: 24220639
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Injured microenvironment directly guides the differentiation of engrafted Flk-1(+) mesenchymal stem cell in lung.
    Yan X; Liu Y; Han Q; Jia M; Liao L; Qi M; Zhao RC
    Exp Hematol; 2007 Sep; 35(9):1466-75. PubMed ID: 17637496
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sca1(+) mesenchymal stromal cells inhibit graft-versus-host disease in mice after bone marrow transplantation.
    Wen F; Zhang HJ; Chen Y; Yue Q; Liu Z; Zhang Q; An N; Chen X; Li N; Xin J; Wang Y; Zhang X; Xu X; Hu X
    Int Immunopharmacol; 2015 May; 26(1):50-7. PubMed ID: 25773667
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mesenchymal stromal cells lose their immunosuppressive potential after allotransplantation.
    Prigozhina TB; Khitrin S; Elkin G; Eizik O; Morecki S; Slavin S
    Exp Hematol; 2008 Oct; 36(10):1370-6. PubMed ID: 18619727
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mesenchymal stem cells inhibit human Th17 cell differentiation and function and induce a T regulatory cell phenotype.
    Ghannam S; Pène J; Moquet-Torcy G; Jorgensen C; Yssel H
    J Immunol; 2010 Jul; 185(1):302-12. PubMed ID: 20511548
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Engrafted bone marrow-derived flk-(1+) mesenchymal stem cells regenerate skin tissue.
    Deng W; Han Q; Liao L; Li C; Ge W; Zhao Z; You S; Deng H; Murad F; Zhao RC
    Tissue Eng; 2005; 11(1-2):110-9. PubMed ID: 15738666
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of tumor-associated stromal cells using SCID GFP transgenic mice: contribution of local and bone marrow-derived host cells.
    Udagawa T; Puder M; Wood M; Schaefer BC; D'Amato RJ
    FASEB J; 2006 Jan; 20(1):95-102. PubMed ID: 16394272
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bone marrow stromal cells use TGF-beta to suppress allergic responses in a mouse model of ragweed-induced asthma.
    Nemeth K; Keane-Myers A; Brown JM; Metcalfe DD; Gorham JD; Bundoc VG; Hodges MG; Jelinek I; Madala S; Karpati S; Mezey E
    Proc Natl Acad Sci U S A; 2010 Mar; 107(12):5652-7. PubMed ID: 20231466
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proliferation-based T-cell selection for immunotherapy and graft-versus-host-disease prophylaxis in the context of bone marrow transplantation.
    Pachnio A; Dietrich S; Klapper W; Humpe A; Schwake M; Sedlacek R; Gramatzki M; Beck C
    Bone Marrow Transplant; 2006 Jul; 38(2):157-67. PubMed ID: 16820783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.